Authors
Loading...
This review evaluates the safety of janus kinase inhibitors in managing active inflammatory bowel disease during pregnancy, suggesting further research is needed.
Colacurci et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: